GPT and metabolic dysfunction-associated steatotic liver disease: Despite indicating the aminotransferases activity (ALT, AST) and their increased level, it has been proven that in 60% of the examined cases these tests are not reliable since the tested parameters may remain within normal limits, even in patients with NAFLD.